Profil
Stephane Depil is former Chief Executive Officer for Netris Pharma, former Chief Medical Officer, EVP-Research & Development at Cellectis SA and former Medical Director-Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
Dr. Depil received a doctorate from Université de Lille III.
Anciens postes connus de Stephane Depil
Sociétés | Poste | Fin |
---|---|---|
CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 01/02/2019 |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Chief Executive Officer | - |
Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Formation de Stephane Depil
Université de Lille III | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CELLECTIS S.A. | Health Technology |
Entreprise privées | 2 |
---|---|
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Health Technology |
Centre Léon Bérard Lyon et Rhône-Alpes |